214 related articles for article (PubMed ID: 23484069)
1. Contributions of the Insulin/Insulin-Like Growth Factor-1 Axis to Diabetic Osteopathy.
Fowlkes JL; Bunn R C; Thrailkill KM
J Diabetes Metab; 2011 Nov; 1(3):. PubMed ID: 23484069
[TBL] [Abstract][Full Text] [Related]
2. Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: differential signalling via Akt and ERK.
Zhang W; Shen X; Wan C; Zhao Q; Zhang L; Zhou Q; Deng L
Cell Biochem Funct; 2012 Jun; 30(4):297-302. PubMed ID: 22249904
[TBL] [Abstract][Full Text] [Related]
3. IGF-I and insulin receptor signal transduction in trout muscle cells.
Castillo J; Ammendrup-Johnsen I; Codina M; Navarro I; Gutiérrez J
Am J Physiol Regul Integr Comp Physiol; 2006 Jun; 290(6):R1683-90. PubMed ID: 16439672
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis.
Perrini S; Natalicchio A; Laviola L; Cignarelli A; Melchiorre M; De Stefano F; Caccioppoli C; Leonardini A; Martemucci S; Belsanti G; Miccoli S; Ciampolillo A; Corrado A; Cantatore FP; Giorgino R; Giorgino F
Endocrinology; 2008 Mar; 149(3):1302-13. PubMed ID: 18079194
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress inhibits insulin-like growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK signaling pathways.
Yin W; Park JI; Loeser RF
J Biol Chem; 2009 Nov; 284(46):31972-81. PubMed ID: 19762915
[TBL] [Abstract][Full Text] [Related]
7. Mono- or dual-phosphorylation of akt kinase is regulated by distinct receptors that involve the common insulin receptor substrate.
Schnyder B; Lahm H; Pittet M; Schnyder-Candrian S
J Recept Signal Transduct Res; 2002; 22(1-4):213-28. PubMed ID: 12503617
[TBL] [Abstract][Full Text] [Related]
8. Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors.
Buck E; Eyzaguirre A; Rosenfeld-Franklin M; Thomson S; Mulvihill M; Barr S; Brown E; O'Connor M; Yao Y; Pachter J; Miglarese M; Epstein D; Iwata KK; Haley JD; Gibson NW; Ji QS
Cancer Res; 2008 Oct; 68(20):8322-32. PubMed ID: 18922904
[TBL] [Abstract][Full Text] [Related]
9. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.
Brüning JC; Winnay J; Cheatham B; Kahn CR
Mol Cell Biol; 1997 Mar; 17(3):1513-21. PubMed ID: 9032279
[TBL] [Abstract][Full Text] [Related]
10. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways.
Celil AB; Campbell PG
J Biol Chem; 2005 Sep; 280(36):31353-9. PubMed ID: 16000303
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.
Richards RG; Walker MP; Sebastian J; DiAugustine RP
J Biol Chem; 1998 May; 273(19):11962-9. PubMed ID: 9565625
[TBL] [Abstract][Full Text] [Related]
12. IRS-1 Functions as a Molecular Scaffold to Coordinate IGF-I/IGFBP-2 Signaling During Osteoblast Differentiation.
Xi G; Shen X; Rosen CJ; Clemmons DR
J Bone Miner Res; 2016 Jun; 31(6):1300-14. PubMed ID: 26773517
[TBL] [Abstract][Full Text] [Related]
13. TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease.
Wu M; Chen G; Li YP
Bone Res; 2016; 4():16009. PubMed ID: 27563484
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.
Giorgino F; Smith RJ
J Clin Invest; 1995 Sep; 96(3):1473-83. PubMed ID: 7544807
[TBL] [Abstract][Full Text] [Related]
15. The IGF-1 Signaling Pathway in Viral Infections.
Józefiak A; Larska M; Pomorska-Mól M; Ruszkowski JJ
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452353
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
Chan TW; Pollak M; Huynh H
Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
[TBL] [Abstract][Full Text] [Related]
17. Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes.
Zhang Y; Moerkens M; Ramaiahgari S; de Bont H; Price L; Meerman J; van de Water B
Breast Cancer Res; 2011 May; 13(3):R52. PubMed ID: 21595894
[TBL] [Abstract][Full Text] [Related]
18. Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts.
Massicotte F; Aubry I; Martel-Pelletier J; Pelletier JP; Fernandes J; Lajeunesse D
Arthritis Res Ther; 2006; 8(6):R177. PubMed ID: 17129375
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2.
Weyman CM; Wolfman A
Endocrinology; 1998 Apr; 139(4):1794-800. PubMed ID: 9528964
[TBL] [Abstract][Full Text] [Related]
20. Fucoidan downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.
Kim IH; Nam TJ
Oncol Rep; 2018 Mar; 39(3):1516-1522. PubMed ID: 29328495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]